More on ADAG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.8 Score)

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Adagene Inc. (NQ:ADAG)
Delayed: 3.59 +0.01 (0.28%)
Prev. Close $3.58  
Open$3.52 
52 Wk High$ 
52 Wk Low$ 
Day High$3.67 
Day Low$3.31 
P/E N/A  
EPS$ 
Volume249,589 

Friends, Peers and Foes (?): SNY (more...)

Jul 14, 2026 06:44 AM Guggenheim Reiterates Buy Rating on Adagene Inc (ADAG)
Jul 6, 2026 08:01 AM Form 6-K Adagene Inc. For: Jul 06
Jun 8, 2026 06:23 AM Form SCHEDULE 13D/A Adagene Inc. Filed by: Luo Peter
May 15, 2026 04:32 PM Form SCHEDULE 13G/A Adagene Inc. Filed by: WuXi PharmaTech Healthcare Fund I L.P.
May 12, 2026 08:30 AM Adagene to Participate in Two Upcoming Investor Conferences
May 7, 2026 11:30 AM Form SCHEDULE 13G Adagene Inc. Filed by: JANUS HENDERSON GROUP PLC
Apr 17, 2026 04:01 PM Adagene presents trial data showing muzastotug combination benefits
Apr 17, 2026 04:01 PM Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
Apr 17, 2026 04:00 PM Form 6-K Adagene Inc. For: Apr 17
Apr 14, 2026 07:01 AM Adagene adds Peter Lebowitz to scientific advisory board
View All Articles

Entities mentioned with ADAG

View All Entities